$IVF stock has now risen 322% today, according to our price data from Polygon. There has been approximately $301,532,975 of trading volume.
Here is what we see in our data on $IVF (you can track the company live on Quiver's $IVF stock page):
$IVF Insider Trading Activity
$IVF insiders have traded $IVF stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $IVF stock by insiders over the last 6 months:
- MATTHEW K SZOT sold 4 shares for an estimated $6
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IVF Hedge Fund Activity
We have seen 8 institutional investors add shares of $IVF stock to their portfolio, and 4 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DRW SECURITIES, LLC added 174,520 shares (+inf%) to their portfolio in Q3 2025, for an estimated $132,617
- CITADEL ADVISORS LLC added 66,849 shares (+inf%) to their portfolio in Q3 2025, for an estimated $50,798
- JANE STREET GROUP, LLC added 41,280 shares (+inf%) to their portfolio in Q3 2025, for an estimated $31,368
- VIRTU FINANCIAL LLC added 16,100 shares (+inf%) to their portfolio in Q3 2025, for an estimated $12,234
- UBS GROUP AG removed 15,916 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $12,094
- MONEY CONCEPTS CAPITAL CORP added 15,558 shares (+inf%) to their portfolio in Q3 2025, for an estimated $11,822
- SBI SECURITIES CO., LTD. removed 5,057 shares (-73.2%) from their portfolio in Q3 2025, for an estimated $3,842
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$IVF Revenue
$IVF had revenues of $1.8M in Q3 2025. This is an increase of 22.6% from the same period in the prior year.
You can track IVF financials on Quiver Quantitative's IVF stock page.
You can track data on $IVF on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
